Show Me Your Care Plan™: Navigating Biomarkers to Guide and Support NSCLC Care

Thanks for your interest in this podcast. Please read this important program information before listening.

Episode Description

In this podcast, experts Benjamin P. Levy, MD; Laura Alder, MD; and Beth Sandy, MSN, CRNP, FAPO, discuss biomarker testing for actionable genomic alterations in non–small cell lung cancer, management of ALK-positive advanced disease, and adjuvant targeted therapy for resectable disease.

Acknowledgment of Educational Grant Support

This activity is supported by an educational grant from Lilly.

Chair:

Benjamin P. Levy, MD

Associate Professor of Oncology
Johns Hopkins University School of Medicine
Clinical Director of Medical Oncology
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Sibley Memorial Hospital
Washington, DC

Faculty:

Laura Alder, MD

Assistant Professor of Medicine
Thoracic Oncology Program
Duke Cancer Institute
Duke University Medical Center
Durham, NC

Beth Sandy, MSN, CRNP, FAPO

Nurse Practitioner, Thoracic Oncology
Abramson Cancer Center
Hospital of the University of Pennsylvania
Philadelphia, PA

This podcast, including the narration, was developed by PER^® editorial staff based on an online activity developed with these faculty. The narration was voiced by a PER staff member or by an AI tool.

To learn more about this topic, including information on the current and emerging treatment landscape for KRAS G12C–mutated non–small cell lung cancer and distinctions among EGFR mutation subtypes, go to https://www.gotoper.com/courses/show-me-your-care-plan-navigating-biomarkers-to-guide-and-support-nsclc-care-6bp4.

Release Date

September 25, 2026

Expiration Date

September 25, 2027

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this activity is for education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER^® or any company that provided commercial support for this activity.